deltatrials
Terminated PHASE3 INTERVENTIONAL 1-arm NCT01286116

A Multinational Trial To Evaluate The Parachute Implant System (PARACHUTE)

A MULTINATIONAL TRIAL TO EVALUATE THE PARACHUTE IMPLANT SYSTEM: PARACHUTE PercutAneous Ventricular RestorAtion in Chronic Heart FailUre Due to Ischemic HearT DiseasE

Sponsor: CardioKinetix, Inc

Interventions Parachute Implant
Updated 6 times since 2017 Last updated: Jun 21, 2017 Started: May 31, 2011 Primary completion: Jan 31, 2013 Completion: Jun 30, 2017
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Company closed

A PHASE3 clinical study on Heart Failure and Myocardial Infarction, this trial is terminated or withdrawn. The trial is conducted by CardioKinetix, Inc and has accumulated 6 data snapshots since 2011. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

~Jan 2017 – ~Jul 2017 · 6 months · monthly snapshotActive Not Recruiting~Jul 2017 – ~Jun 2018 · 11 months · monthly snapshotTerminated~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotTerminated~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

6 versions recorded
  1. Sep 2024 — Present [monthly]

    Terminated PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE3

  3. Jan 2021 — Jul 2024 [monthly]

    Terminated PHASE3

  4. Jun 2018 — Jan 2021 [monthly]

    Terminated PHASE3

  5. Jul 2017 — Jun 2018 [monthly]

    Terminated PHASE3

    Status: Active Not RecruitingTerminated

Show 1 earlier version
  1. Jan 2017 — Jul 2017 [monthly]

    Active Not Recruiting PHASE3

    First recorded

May 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • CardioKinetix, Inc
Data source: CardioKinetix, Inc

For direct contact, visit the study record on ClinicalTrials.gov .